![Torgny H. Svensson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Torgny H. Svensson
Corporate Officer/Principal bij Karolinska Institutet
Actieve functies van Torgny H. Svensson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Karolinska Institutet | Corporate Officer/Principal | - | - |
Loopbaan van Torgny H. Svensson
Eerdere bekende functies van Torgny H. Svensson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Independent Pharmaceutica AB
![]() Independent Pharmaceutica AB Medical DistributorsDistribution Services Independent Pharmaceutica AB is a privately owned company. The major owners are Karolinska Investment Fund, LH Advisory, Sandin &Co and The Foundation for Baltic and East European Studies (Östersjöstiftelsen). Independent Pharmaceutica aims to provide pharmacological solutions for treatment of nicotine addiction. The company is spun out of research from the Karolinska Institutet in Stockholm, Sweden. Tobacco use is the leading preventable cause of morbidity and premature death in the world.Currently over 1.2 billion people smoke worldwide and the number of annual deaths from tobacco-related diseases is over 4 million and rising. The costs for society are huge. With the new vaccine Niccine® against nicotine addiction, the health condition of millions of patients is expected to be improved. | Hoofd Techniek/Wetenschap/O&O | 01-01-1997 | 25-11-2009 |
Oprichter | 25-11-2009 | 20-10-2011 | |
Corporate Officer/Principal | 25-11-2009 | 20-10-2011 |
Statistieken
Internationaal
Zweden | 3 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Distribution Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Independent Pharmaceutica AB
![]() Independent Pharmaceutica AB Medical DistributorsDistribution Services Independent Pharmaceutica AB is a privately owned company. The major owners are Karolinska Investment Fund, LH Advisory, Sandin &Co and The Foundation for Baltic and East European Studies (Östersjöstiftelsen). Independent Pharmaceutica aims to provide pharmacological solutions for treatment of nicotine addiction. The company is spun out of research from the Karolinska Institutet in Stockholm, Sweden. Tobacco use is the leading preventable cause of morbidity and premature death in the world.Currently over 1.2 billion people smoke worldwide and the number of annual deaths from tobacco-related diseases is over 4 million and rising. The costs for society are huge. With the new vaccine Niccine® against nicotine addiction, the health condition of millions of patients is expected to be improved. | Distribution Services |
- Beurs
- Insiders
- Torgny H. Svensson
- Ervaring